Wall Street is on pace to snap a 2-session losing streak thanks to a string of earnings beats. Nothing really happening on the economic data front heading into the weekend, so earnings season is the domestic driver. Internationally, investors are keeping an eye on both the IMF meetings and the French presidential election. Both have huge implications on whether the EU will finally be able to put aside sovereign debt concerns.
Stryker Corp. (NYSE:SYK) closed Thursday down 1.98% at $54.36. SYK tarded 2.1 million shares yesterday, above its daily average of 1.8 million shares. Ronda Stryker (Director) sold 9,000 shares at $55.56 on April 18.
Xerox Corp. (NYSE:XRX) fell 0.63% yesterday at $7.91. Volume was lighter than usual for Xerox with 9.3 million shares traded. XRX usually trades 11.9 million shares a day on average. James Firestone (Executive Vice President) sold 76,877 shares at $8.00 on April 17.
PartnerRe Ltd. (NYSE:PRE) rose 1.61% on Thursday at $67.41. PRE has traded 480 thousand shares so far today, 70 thousand shares more than its daily average. Theodore Walker (President & CEO) sold 631 shares at $67.06 on April 18.
The Goldman Sachs Group, Inc. (NYSE:GS) went down 1.50% yesterday at $113.60. GS traded 7.8 million shares yesterday, well above its daily average of 6.4 million shares. Goldman Sachs Group Inc. (10% owner) sold 5,6181,818 shares at $19.74 on April 17.
Darden Restaurants, Inc. (NYSE:DRI) fell 1.04% on Thursday and closed at $49.71. DRI has traded 1.4 million shares yesterday and trades 1.9 million shares a day on average. Leonard Berry (Director) sold 3,000 shares at $50.10 on April 18.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) went up 3.09% Thursday at $36.66. VRTX traded 1.9 million shares on Thursday and trades averages 2.8 million shares daily. Joshua Boger (Director) sold 4,000 shares at $35.88 on April 18.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) jumped 1.53% yesterday at $125.99. REGN traded 742 thousand shares yesterday and trades just over a million shares a day on average. Charles Baker (Director) sold 12,910 shares at $125.00 on April 19.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) jumped 3.91% on Thursday at $1.33. KERX traded 1.9 million shares yesterday and trades 3.3 million shares a day on average. Ron Bentsur (CEO) bought 19,100 shares at $1.30 on April 18.